GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 343 filers reported holding GLOBUS MED INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,829,872 | +2338637.2% | 56,997 | +201.3% | 0.02% | +15.4% |
| Q2 2023 | $121 | -95.6% | 18,917 | -50.2% | 0.01% | -40.9% |
| Q4 2022 | $2,769 | -99.9% | 37,975 | -0.1% | 0.02% | +4.8% |
| Q3 2022 | $2,457,000 | +7.3% | 38,006 | -3.8% | 0.02% | +10.5% |
| Q2 2022 | $2,290,000 | -29.6% | 39,507 | -1.1% | 0.02% | -20.8% |
| Q1 2022 | $3,252,000 | +32.0% | 39,958 | +6.8% | 0.02% | +33.3% |
| Q4 2021 | $2,464,000 | -18.6% | 37,410 | -1.2% | 0.02% | 0.0% |
| Q3 2021 | $3,028,000 | -12.3% | 37,879 | -15.2% | 0.02% | -14.3% |
| Q2 2021 | $3,452,000 | +6.2% | 44,685 | -2.3% | 0.02% | +10.5% |
| Q1 2021 | $3,252,000 | -16.0% | 45,728 | -22.8% | 0.02% | -24.0% |
| Q4 2020 | $3,872,000 | +14.9% | 59,269 | -5.6% | 0.02% | +4.2% |
| Q3 2020 | $3,370,000 | +45.7% | 62,793 | +29.5% | 0.02% | +33.3% |
| Q2 2020 | $2,313,000 | +5.5% | 48,483 | +3.4% | 0.02% | -10.0% |
| Q1 2020 | $2,192,000 | -8.9% | 46,871 | +3.8% | 0.02% | +11.1% |
| Q4 2019 | $2,405,000 | +7.8% | 45,172 | +1.3% | 0.02% | 0.0% |
| Q3 2019 | $2,230,000 | +16.4% | 44,608 | -1.0% | 0.02% | +20.0% |
| Q2 2019 | $1,916,000 | -20.6% | 45,039 | -11.1% | 0.02% | -25.0% |
| Q1 2019 | $2,414,000 | +6.8% | 50,680 | -2.6% | 0.02% | +5.3% |
| Q4 2018 | $2,260,000 | -12.0% | 52,019 | +7.3% | 0.02% | -9.5% |
| Q3 2018 | $2,569,000 | -13.5% | 48,483 | -13.7% | 0.02% | 0.0% |
| Q2 2018 | $2,971,000 | +1.3% | 56,177 | -2.2% | 0.02% | 0.0% |
| Q1 2018 | $2,934,000 | +13.5% | 57,435 | -0.0% | 0.02% | +23.5% |
| Q4 2017 | $2,585,000 | +45.3% | 57,451 | +0.8% | 0.02% | +30.8% |
| Q3 2017 | $1,779,000 | -3.9% | 57,016 | -0.1% | 0.01% | -7.1% |
| Q2 2017 | $1,851,000 | +7.2% | 57,083 | +1.1% | 0.01% | +7.7% |
| Q1 2017 | $1,726,000 | +17.3% | 56,474 | +4.8% | 0.01% | +8.3% |
| Q4 2016 | $1,472,000 | +48.8% | 53,878 | +27.0% | 0.01% | +33.3% |
| Q2 2016 | $989,000 | -5.2% | 42,430 | -3.0% | 0.01% | 0.0% |
| Q1 2016 | $1,043,000 | -8.8% | 43,727 | -2.7% | 0.01% | -18.2% |
| Q4 2015 | $1,144,000 | +22.9% | 44,931 | -0.3% | 0.01% | +22.2% |
| Q3 2015 | $931,000 | -60.6% | 45,069 | -51.0% | 0.01% | -10.0% |
| Q2 2015 | $2,360,000 | +97.7% | 91,902 | +94.3% | 0.01% | 0.0% |
| Q1 2015 | $1,194,000 | -47.9% | 47,307 | -50.9% | 0.01% | 0.0% |
| Q4 2014 | $2,290,000 | +127.4% | 96,336 | +88.2% | 0.01% | +11.1% |
| Q3 2014 | $1,007,000 | +27.0% | 51,176 | +54.4% | 0.01% | +28.6% |
| Q2 2014 | $793,000 | -21.5% | 33,146 | -12.7% | 0.01% | -12.5% |
| Q1 2014 | $1,010,000 | -25.1% | 37,986 | -43.2% | 0.01% | -20.0% |
| Q4 2013 | $1,349,000 | +3.9% | 66,866 | -10.0% | 0.01% | +11.1% |
| Q3 2013 | $1,298,000 | +9.7% | 74,325 | +5.9% | 0.01% | -10.0% |
| Q2 2013 | $1,183,000 | – | 70,187 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |